<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T04:29:17Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/11167" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/11167</identifier><datestamp>2026-09-24T06:01:49Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Smieja, Marek Jozef</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Thabane, Lehana</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Andrew McIvor, Fiona Smaill</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Cui, Qu</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Health Research Methodology</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2014-06-18T16:53:46Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2014-06-18T16:53:46Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="created" lang="en_US">2011-09-12</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2011-10</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">opendissertations/6156</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">7161</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">2231208</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/11167</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/18671</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">&lt;p>Cigarette smoking is prevalent in HIV-infected people, resulting in higher mortality rate and more premature heart and lung diseases in the highly active antiretroviral therapy era. Smoking is a modifiable risk factor for these adverse outcomes and smoking cessation in HIV-positive smokers is feasible, although further efforts are needed to improve smoking cessation programs in HIV-positive persons.&lt;/p> &lt;p>In this thesis, I examined the role of smoking in mortality and morbidity in HIV-positive Ontarians, and piloted a smoking cessation program featuring a novel smoking cessation aid, varenicline, in HIV-infected smokers. In addition, I explored three different methods to resolve missing data, by excluding, grouping and multiply imputing missing data. I adopted three different study designs in my thesis studies: retrospective cohort, cross-sectional and open label study.&lt;/p> &lt;p>We found smoking prevalence in HIV-infected people was consistently higher than in the general population. Smoking was associated with a higher risk of death, of respiratory symptoms, hospitalization and chronic obstructive pulmonary disease, and with reduced lung function and less CD4-T-lymphocyte improvement over time. We found varenicline was as effective in HIV-positive smokers as in non-HIV smokers reported by previous studies.&lt;/p></dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Doctor of Philosophy (PhD)</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">HIV</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">smoking</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">smoking cessation</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">multiple imputation</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">varenicline</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Canada</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Clinical Epidemiology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Clinical Epidemiology</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">EFFECT OF SMOKING AND CESSATION IN HIV-INFECTED PEOPLE</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>